Product Center
The 7th China (Taizhou) International Pharmaceutical Expo Was Successfully Held
- Categories:Industry news
- Author:
- Origin:
- Time of issue:2016-10-31
- Views:
(Summary description)On October 28, 2016, the 7th China (Taizhou) International Pharmaceutical Expo was successfully held! Taizhou, China has focused the world's attention and has become a global focal point. Ab&B Bio-Tech Co., Ltd. (JS) is also on the list again!
The 7th China (Taizhou) International Pharmaceutical Expo Was Successfully Held
(Summary description)On October 28, 2016, the 7th China (Taizhou) International Pharmaceutical Expo was successfully held! Taizhou, China has focused the world's attention and has become a global focal point. Ab&B Bio-Tech Co., Ltd. (JS) is also on the list again!
- Categories:Industry news
- Author:
- Origin:
- Time of issue:2016-10-31 10:57
- Views:
On October 28, 2016, the 7th China (Taizhou) International Pharmaceutical Expo was successfully held! Taizhou, China has focused the world's attention and has become a global focal point. Ab&B Bio-Tech Co., Ltd. (JS) is also on the list again!
Relevant information
-
Deepening Strategic Synergy to Jointly Strengthen Public Health Defense: Chongqing Center for Disease Control and Prevention (Chongqing Institute of Preventive Medicine) visited Ab&B Bio for a visit and exchange session.On August 5, 2026, a delegation comprising leaders and experts from the Chongqing Center for Disease Control and Prevention (Chongqing Institute of Preventive Medicine) visited Ab&B Bio-Tech CO.,LTD.JS to conduct an on-site inspection and hold a symposium. During the meeting, both parties engaged in in-depth discussions on topics such as innovative vaccine R&D, clinical evaluation, joint construction of technical platforms, sharing of data resources, talent cultivation, and technology commercialization, thereby accelerating the transition of their strategic cooperation from "paper-based consensus" to "substantive implementation." - The world's first! The monkeypox mRNA vaccine has obtained dual clinical trial approvals from both China and the United States. 07-02
- Phase I/II Clinical Trial of the Re engineered Respiratory Syncytial Virus Vaccine (CHO Cells)(Adjuvant)Officially Launched 05-13
- The mRNA technology platform has achieved another milestone, with global innovation efforts accelerating. 05-08
- Our innovative vaccine research team won the 20th "Jiangsu Youth May Fourth Medal Collective" award 04-27
Got a project? Contact us today !
At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.
Contact
E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
